Bottom line
Is IHI a good fund? The bottom line
IHI is a managed health care sector ETF from iShares.
It charges 0.37% — about $37 a year on every $10,000 invested, cheaper than 87% of health care sector funds we track.
It returned +6.9% over one year, +3.1% a year over five years, +12.2% a year over ten (as of Dec 31, 2025, per its prospectus).
With $3.0 billion in net assets and 50 holdings, its largest position is Abbott Laboratories (16.9%) and the top 10 make up 74.6% of the portfolio.
What stands out
- Low cost: cheaper than 87% of health care sector peers
What to watch
- Concentrated: top 10 holdings are 74.6% of assets
Updated Nov 19, 2026
What IHI invests in
The iShares U.S. Medical Devices ETF (the Fund ) seeks to track the investment results of an index composed of U.S. equities in the medical devices sector.
The Fund seeks to track the investment results of the Dow Jones U.S. Select Medical Equipment Index (the Underlying Index ), which measures the performance of the medical equipment sector of the U.S. equity market, as defined by S&P Dow Jones Indices LLC (the Index Provider or SPDJI ). The Underlying Index includes medical equipment companies, including manufacturers and distributors of medical devices such as magnetic resonance imaging (MRI) scanners, prosthetics, pacemakers, X-ray machines, and other nondisposable medical devices. The Underlying Index may include large-, mid- or small-capitalization companies. As of March 31, 2026, a significant portion of the Underlying Index was represented by securities of companies in the healthcare and medical equipment industries or sectors. The components of the Underlying Index are likely to change over time. The Fund seeks to track the…
From the fund's prospectus (filed Jul 27, 2026).
IHI performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| IHI | +6.9% | +3.1% | +12.2% |
| Health Care Sector median | +14.5% | +4.2% | +7.9% |
Source: Fund prospectus, as of Dec 31, 2025
What IHI costs
On a $10,000 investment, IHI's 0.37% expense ratio costs about $37 a year. The prospectus estimates $468 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.
IHI top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Abbott Laboratories | 16.93% |
| 2 | Intuitive Surgical, Inc. | 15.09% |
| 3 | Stryker Corporation | 11.64% |
| 4 | Edwards Lifesciences Corporation | 4.75% |
| 5 | Becton, Dickinson And Company | 4.63% |
| 6 | Ge Healthcare Technologies Inc. | 4.51% |
| 7 | Medtronic Public Limited Company | 4.40% |
| 8 | Resmed Inc. | 4.38% |
| 9 | Idexx Laboratories, Inc. | 4.27% |
| 10 | Dexcom, Inc. | 4.02% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 74.6% of the fund. See all top 25 holdings and asset mix →